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use#LAAThis year’s Joint Keystone Symposium on Epigenomics 
and  Chromatin  Dynamics  was  one  of  the  largest 
Keystone meetings to date, reflecting the excitement and 
many developments in this area. Richard Young opened 
the meeting by giving a historic overview before sharing 
more detailed insights from his recent work in describing 
the role of the lysine demethylase Lsd1 in mouse embry­
onic stem (ES) cell differentiation. He also set the broader 
stage and highlighted the excitement concerning recent 
advances  in  epigenetic  drugs  such  as  the  new  bromo­
domain inhibitors.
DNA methylation
Plants and algae
Co­organizer  Steven  Jacobsen  reported  his  team’s  dis­
covery of two novel ATPase­encoding genes in Arabidopsis 
thaliana that are involved in maintaining the repression 
of  endogenous  transposable  elements  (TEs).  Using  a 
double mutant strain, they discovered that the activation 
of these genes was concomitant with increased histone 
acetylation,  but  that  it  did  not  require  loss  of  DNA 
methy  lation.  Robert  Fischer  discussed  the  role  of 
DEMETER (DME) in transposon silencing. Loss of DME 
does  not  affect  methylation  in  endosperm  cells  but 
increased  it  within  maternal  TEs.  Activation  of  TEs 
through demethylation by DME in vegetative cells pro­
duces small RNAs, which Robert Martienssen described 
as  epigenetically  activated  siRNAs  (easiRNAs).  These 
easiRNAs translocate to sperm and silence the same TEs 
that they were generated from. Joseph Ecker reported that 
epivariations  occur  five  orders  of  magnitude  more  fre­
quently than spontaneous genetic mutation in genetically 
matched Arabidopsis thaliana cohorts. Using DNA methy­
lation  patterns  in  different  families  of  distantly  related 
algae, Daniel Zilberman identified a distinct DNA methy­
lation pattern that supports the evolu  tionary origins of the 
DNMT5  protein,  a  DNA  methyltransferase  with  ATP­
dependent nucleosome remodeling capabilities.
Mammals and methylomes
By examining DNA methylation in early developmental 
stages of heterozygous Dnmt3l mice, Deborah Bourc’his 
identified several novel imprinting control regions (ICRs), 
including  a  new  class  of  transiently  methylated  ICRs. 
Alexander Meissner presented a comprehensive charac­
terization  of  DNA  methylation  dynamics  in  the  early 
mouse  embryo  and  in  reconstructed  embryos  after 
nuclear transfer. Andrew Feinberg provided evidence for 
the existence of large genomic regions that are charac­
terized by high variability in DNA methylation between 
individual tumors, and proposed an evolutionary model 
that suggests a positive selection for molecular mecha­
nisms that allow epigenetic drift. Timothy Bestor showed 
results  from  a  restriction  enzyme­based  genome­wide 
DNA  methylation  assay.  This  assay  suggests  that  DNA 
methylation levels have been overestimated by bisulfite­
based approaches, which he believes erroneously led to 
the notion that DNA hypermethylation at genes encoding 
tumor suppressors contributes to cancer.
Peter Jones described the use of nucleosome occupancy 
methylome  sequencing  (NOMe­Seq)  to  confirm  that 
active  enhancers  exhibit  nucleosome  depletion  in  con­
junc  tion  with  low  levels  of  DNA  methylation.  He  also 
presented  evidence  that  nucleosomes  assemble  first, 
before acquiring DNA methylation during the silencing 
of enhancers. Jones concluded his talk by presenting data 
on  the  promoter  of  MLH1,  an  example  of  a  tumor 
suppressor  gene  that  is  aberrantly  silenced  by  DNA 
methylation  in  primary  colon  tumors.  Asaf  Hellman 
reported studies on the methylation state of 93 CpG sites 
in regions that have previously been associated with type 
2 diabetes. This work led to the identification of a subset 
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© 2012 BioMed Central Ltdof hypomethylated regions that are unique to the afflicted 
cohort. Additionally, he provided evidence suggesting that 
the establishment of these hypomethylated regions pre­
cedes disease onset.
Bing Ren described the use of divergent mouse strains 
to  track  parent­of­origin  methylation,  unveiling  several 
novel allele­specific methylated regions. Gregory Hannon 
showed  that  hypomethylated  regions  can  impact  gene 
expression and genome organization. Keji Zhao charac­
ter  ized  the  spatial  interactions  of  gene  regulatory  ele­
ments  within  the  genome  using  chromatin  interaction 
analysis by paired­end tag sequencing (CHIA­PET). He 
also presented evidence that Mecp2 (methyl CpG binding 
protein 2) and gene body DNA methylation are involved 
in facilitating faithful exon inclusion, providing a direct 
link between DNA methylation and splicing.
Hydroxymethylcytosine and the Tet family
Nathaniel Heintz reported on how his group had profiled 
hydroxymethylcytosine (hmC) conversion in three types 
of  neural  cells.  High  levels  of  methylcytosine  (mC) 
clustered in nuclei and correlated with heterochromatin, 
but  hmCs  are  dispersed  and  appear  to  be  located 
predominantly in gene bodies. Anjana Rao showed that, 
within  the  Tet  family  of  nucleic  acid­binding  proteins, 
Tet1  mainly  binds  to  transcription  start  sites,  whereas 
Tet2 mainly localizes within gene bodies and exons, and 
that knockdown of Tet2 results in greater reduction in 
hmC levels than does depletion of Tet1 in ES cells. She 
also proposed that IDAX, the transposed CXXC domain 
of Tet2, regulates Tet2 post­transcriptionally.
Thomas Fazzio showed that the chromatin regulators 
Mbd3 and Brg1 regulate genes antagonistically by regu­
lat  ing  promoter­proximal  nucleosome  occupancy  and 
RNA polymerase II (PolII) recruitment. Notably, Mbd3 
co­localizes  with  Tet1  and  seems  to  bind  hmC,  which 
appears  to  be  supported  by  the  distinct  tyrosine  to 
phenylalanine switch in the binding pocket. Finally, Wolf 
Reik showed that in reprogramming to pluripotency, Tet1 
preserved the unmethylated status of many pluripotency­
related genes. Co­expression of Tet1 and the pluripotency 
maintenance  factor  Nanog  dramatically  enhanced  the 
reprogramming of epiblast stem cells (EpiSCs) to induced 
pluripotent stem cells (iPSCs). The expression of Tet1 in 
EpiSCs leads to the demethylation of its own differentially 
methylated region (DMR), whereas deletion of Tet1 in ES 
cells leads to the methylation of its DMR.
Chromatin biology
Pluripotency
Kathrin Plath continued her detailed analysis of ‘X re­
activation’ dynamics during reprogramming to pluri  potency 
and  compared  it  to  X  inactivation  during  embry  onic 
development. She noted that reverse dynamics appear to 
be occurring, with the exception of DNA methy  lation, 
which remains a terminal barrier to reactivation. Amanda 
Fisher described the effect of different cell­cycle phases 
on reprogramming potential and found that S/G2­phase 
mouse  ES  cells  reprogram  human  lymphocytes  more 
efficiently than do G1­phase cells. She then showed that 
fusion with embryonic germ (EG) cells, but not ES cells, 
could  erase  genomic  imprinting,  and  that  this  process 
was both replication dependent and independent. Bradley 
Bernstein presented chromatin state data for many cell 
types,  and  identified  potentially  novel  transcriptional 
regulators  on  the  basis  of  the  chromatin  signature  at 
enhancers. He then presented genome­wide binding data 
for  various  chromatin  modifiers  that,  in  combination 
with  transcriptional  status,  had  allowed  his  group  to 
define distinct chromatin state modules in two human 
cell types. Ana Pombo showed data describing a novel 
PolII  variant  that  is  specifically  enriched  at  Polycomb 
repressive complex (PRC)­bound genes.
Regulators and remodeling
Genevieve Almouzni described how the histone chaperone 
NASP  (Nuclear  autoantigenic  sperm  protein)  protects 
soluble  H3/H4  dimers  from  chaperone­mediated  auto­
phagy, thus fine­tuning the amount of histones available 
for  nucleosome  assembly.  Bradley  Cairns  provided 
evidence to support an autoinhibitory model governing 
sliding of the ISWI (imitation switch family) of chromatin 
remodeling ATPases. Interestingly, one domain present 
on the amino terminus serves as an H4 mimic, which 
conformationally inhibits ATP catalysis in the absence of 
histone binding. Timothy Richmond provided structural 
work  supporting  a  dinucleosomal  substrate  for  ISW1a 
binding: one nucleosome acts as a stable spool while the 
other is brought towards it. Blaine Bartholomew showed 
mutant data relating to the slide domain within the HSS 
(Hand Sant Slide) of ISW2. These data suggest that four 
basic residues are essential for DNA contact and for the 
entry of linker DNA into the remodeled nucleosome.
To  model  compaction  mediated  by  polycomb  group 
components in a simplified system, Robert Kingston had 
examined the structural interaction between yeast Sir3 
and the nucleosome, which is also responsible for hetero­
chromatin  compaction.  He  reported  a  large  positively 
charged surface within the BAH domain that provides 
the largest contact with histones and few contacts with 
DNA. This interaction might serve as the primary dock­
ing  mechanism  through  which  larger  heterochromatin 
structures are assembled. Gerald Crabtree expanded on 
the  nuanced  regulatory  role  of  BAF  complexes  in 
neuronal differentiation and reprogramming. Switching 
of  only  a  few  components  within  this  large  complex 
appears  to  influence  genomic  targets  strongly  and  can 
dramatically  affect  cell  fate.  Ali  Shilatifard  presented 
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and PolII elongation factors can recruit the SEC (super 
elongation complex) to target genes, licensing aberrant 
elongation  by  PolII.  Joanna  Wysocka  presented  recent 
findings on enhancer dynamics in development using a 
human  ES­cell­based  model  of  cranial  neural  crest 
formation.  ChIP­seq  profiling  of  the  neural  crest  cell 
enhancer  repertoire,  along  with  sequence  analyses  of 
predicted transcription factor binding sites, enabled the 
identification of the COUP (chicken ovalbumin upstream 
promoter) family of orphan nuclear receptors as novel 
regulators of craniofacial development. This strategy also 
identified  the  transcription  factor  AP2  as  a  major 
specifier of the neural crest lineage.
Rena  Levin­Klein  described  experiments  elucidating 
the non­random nature of allelic exclusion in developing 
B cells, which has an epigenetic basis at immunoglobulin 
genes involving monoallelic H3K4me3 deposition at DJ 
exons slated for removal. Utilizing a large mutant library 
for  histone  residues  and  chromatin  modifiers  in  yeast, 
Oliver Rando addressed the lingering discrepancy between 
the widespread association of chromatin modifications to 
transcriptional  regulation  and  the  limited  phenotypic 
effects upon depletion. Inkyung Jung presented his most 
recent  results  from  the  gene  expression  profiling  of  a 
large  histone  mutant  library  in  yeast,  and  was  able  to 
confirm  an  association  of  H3K56  methylation  with 
nucleo  some  positioning.  David  Katz  reported  on  the 
functional role of the histone demethylase LSD1/KDM1 
during epigenetic reprogramming using Caenorhabditis 
elegans  and  mouse  models.  Paul  Soloway  presented  a 
novel technique for the isolation of single nucleosomes 
using a microfluidics approach similar to that employed 
for flow cytometry, which could open the door to single 
molecule and single cell epigenomics.
Architecture
Job Dekker used 5C technology to reveal that the majority 
of genomic looping interactions are cell type specific and 
can skip CTCF binding sites, and that enhancers do not 
always  interact  with  the  nearest  gene  in  genomic  co­
ordinates. Wendy Bickmore investigated the regulation 
of  the  HOX  locus  using  5C  and  fluorescence  in  situ 
hybridization  (FISH)  technology.  Although  the  loss  of 
PRC1  and  PRC2  leads  to  chromatin  decompaction,  an 
increase in histone acetylation is also sufficient to induce 
chromatin decompression and basal expression, even in 
the  presence  of  active  PRC  complexes  at  this  locus. 
Shalini  Oberdoerffer  received  the  Herb  Tabor  young 
investigator award preceding her presentation on PolII 
pausing during alternative pre­mRNA splicing. She had 
found  that  in  the  absence  of  exon  splicing  enhancers, 
CTCF binding in the proximity of an exon leads to PolII 
pausing and exon inclusion. Consistently, global analysis 
of  CTCF  depletion  revealed  exon  exclusion  when  the 
CTCF  site  was  located  downstream  of  the  exon, 
highlighting  another  CTCF  function.  Bas  van  Steensel 
discussed  lamina­associated  domains  (LADs),  which 
predominantly include inactive genes and show low PolII 
occupancy.  Using  a  GFP­fusion  protein  to  observe  the 
single­cell dynamics of LADs, he showed that although 
LADs  are  dynamic,  their  interaction  with  the  nuclear 
periphery  is  spatially  constrained.  Matthias  Merken­
schlager’s group performed gene expression analysis and 
chromatin  conformation  capture  techniques  to  investi­
gate  the  role  of  cohesin  in  gene  expression  and  long­
range chromatin interactions. Steven Henikoff presented 
results obtained using a micrococcal nuclease (MNase)­
based approach to identify transcription factor footprints 
and  the  nearby  chromatin­remodeling  complexes.  This 
novel approach provides striking resolution in revealing 
the  interaction  of  gene  regulatory  elements  and  their 
associated protein complexes.
Conclusions and future outlook
Exciting  technical  advancements  in  recent  years  have 
influenced the scope of many projects and continue to 
drive  the  field  forward  at  a  rapid  pace.  Despite  the 
increasing number of whole­genome datasets now avail­
able,  many  interesting  questions  remain  unanswered. 
This brief report only begins to acknowledge many of the 
exciting projects and ideas presented at this meeting, but 
should serve as an indicator of the powerful information 
that will undoubtedly come out of the epigenomics and 
chromatin biology field in the coming years.
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